These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 28267080)
1. ATIC Gene Polymorphism and Histologic Response to Chemotherapy in Pediatric Osteosarcoma. Park JA; Shin HY J Pediatr Hematol Oncol; 2017 Jul; 39(5):e270-e274. PubMed ID: 28267080 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients? Salazar J; Moya P; Altés A; Díaz-Torné C; Casademont J; Cerdà-Gabaroi D; Corominas H; Baiget M Pharmacogenomics; 2014 Jun; 15(8):1079-90. PubMed ID: 25084201 [TBL] [Abstract][Full Text] [Related]
3. ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis. Muralidharan N; Mariaselvam CM; Jain VK; Gulati R; Negi VS Pharmacogenomics; 2016 Feb; 17(3):241-8. PubMed ID: 26799664 [TBL] [Abstract][Full Text] [Related]
4. ATIC missense variant affects response to methotrexate treatment in rheumatoid arthritis patients. Kurzawski M; Malinowski D; Szarmach N; Nowak A; Goryniak A; Pawlik A; Droździk M Pharmacogenomics; 2016 Dec; 17(18):1971-1978. PubMed ID: 27885916 [TBL] [Abstract][Full Text] [Related]
5. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms. Lima A; Monteiro J; Bernardes M; Sousa H; Azevedo R; Seabra V; Medeiros R Biomed Res Int; 2014; 2014():368681. PubMed ID: 24967362 [TBL] [Abstract][Full Text] [Related]
6. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity. Sala-Icardo L; Lamana A; Ortiz AM; García Lorenzo E; Moreno Fresneda P; García-Vicuña R; González-Álvaro I Reumatol Clin; 2017; 13(6):318-325. PubMed ID: 27751863 [TBL] [Abstract][Full Text] [Related]
7. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis. Milic V; Jekic B; Lukovic L; Bunjevacki V; Milasin J; Novakovic I; Damnjanovic T; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Pejnovic N; Krajinovic M Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981 [TBL] [Abstract][Full Text] [Related]
8. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis. Lee YH; Bae SC Rheumatol Int; 2016 Nov; 36(11):1591-1599. PubMed ID: 27379764 [TBL] [Abstract][Full Text] [Related]
9. Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate. Jabeen S; Holmboe L; Alnæs GI; Andersen AM; Hall KS; Kristensen VN Pharmacogenomics J; 2015 Oct; 15(5):385-90. PubMed ID: 25778468 [TBL] [Abstract][Full Text] [Related]
10. Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate. Lee YC; Cui J; Costenbader KH; Shadick NA; Weinblatt ME; Karlson EW Rheumatology (Oxford); 2009 Jun; 48(6):613-7. PubMed ID: 19193698 [TBL] [Abstract][Full Text] [Related]
11. Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients. Singh A; Gangadharan H; Gupta V; Patro PS; Misra R; Aggarwal A Int J Rheum Dis; 2021 May; 24(5):654-662. PubMed ID: 33780152 [TBL] [Abstract][Full Text] [Related]
12. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444 [TBL] [Abstract][Full Text] [Related]
13. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis. Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602 [TBL] [Abstract][Full Text] [Related]
14. Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma. Park JA; Shin HY Blood Res; 2016 Mar; 51(1):50-7. PubMed ID: 27104192 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis. Campalani E; Arenas M; Marinaki AM; Lewis CM; Barker JN; Smith CH J Invest Dermatol; 2007 Aug; 127(8):1860-7. PubMed ID: 17410198 [TBL] [Abstract][Full Text] [Related]
16. Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma. Linnebank M; Moskau S; Jürgens A; Simon M; Semmler A; Orlopp K; Glasmacher A; Bangard C; Vogt-Schaden M; Urbach H; Schmidt-Wolf IG; Pels H; Schlegel U Neuro Oncol; 2009 Feb; 11(1):2-8. PubMed ID: 18806228 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. Owen SA; Hider SL; Martin P; Bruce IN; Barton A; Thomson W Pharmacogenomics J; 2013 Jun; 13(3):227-34. PubMed ID: 22450926 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443 [TBL] [Abstract][Full Text] [Related]
19. Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis. Weisman MH; Furst DE; Park GS; Kremer JM; Smith KM; Wallace DJ; Caldwell JR; Dervieux T Arthritis Rheum; 2006 Feb; 54(2):607-12. PubMed ID: 16447238 [TBL] [Abstract][Full Text] [Related]
20. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression. Patiño-García A; Zalacaín M; Marrodán L; San-Julián M; Sierrasesúmaga L J Pediatr; 2009 May; 154(5):688-93. PubMed ID: 19159907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]